Acute respiratory infections are responsible for an estimated 4 million deaths annually worldwide, and are the leading cause of death in children younger than 5 years.
Over 1 million people in the United States are hospitalized each year with pneumonia.
Mycobacterium tuberculosis infects one third of world’s population.
There are more than 1 million tuberculosis-related deaths worldwide each year.
Emerging resistance to multiple available antimicrobial agents has hampered the ability to treat tuberculosis and hospital-acquired respiratory infections.
The laboratory diagnosis of respiratory infections is an important part of patient management and treatment.
In addition to culture isolation of pathogens, advances have been made in a number of non-culture methods.
This issue of Clinics in Laboratory Medicinee reviews state-of-the-art laboratory diagnosis of respiratory infections, as well as the testing of susceptibility to antibiotics and antiviral agents.
Among some of the respiratory infections covered are: Cystic fibrosis infections; Pertussis; Pharyngitis; Fungal infections.
Among the diagnostic tests are: Interferon gamma release assays; Molecuar diagnosis of TB; Urine antigen tests and discussion of Antibiotic resistance in nosocomial respiratory infections.
Recenzii
Nicio recenzie găsită.